)
Ashland (ASH) investor relations material
Ashland Q1 2026 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Executive summary
Q1 results were solid with steady execution and cost discipline, despite ongoing demand softness in coatings and construction, operational challenges, and isolated disruptions; net loss improved to $12 million from $165 million, driven by the absence of large impairment charges and improved performance.
Life Sciences achieved healthy growth, driven by resilient pharma demand and innovation; Personal Care remained stable with double-digit growth in biofunctional actives, while Specialty Additives and Intermediates faced muted demand but benefited from cost actions.
Early Q2 sales trends are encouraging, with resilience in key segments and solid free cash flow despite weather and operational disruptions.
Exited the quarter with improving momentum, particularly in December and January.
Financial highlights
Q1 sales were $386 million, down 5% year-over-year, mainly due to lower volume, Avoca divestiture, and pricing pressure; excluding Avoca, sales declined 3%.
Adjusted EBITDA was $58 million, down 5% year-over-year, with a 15% margin; excluding Avoca, down 3%.
Adjusted EPS (ex-intangible amortization) was $0.26, down 7% year-over-year; gross profit margin improved by 120 bps to 29.3%.
Operating cash flow was $125 million, aided by a $103 million tax refund; free cash flow $26 million, with nearly 50% conversion.
Liquidity at quarter-end was ~$900 million; net debt $1.1 billion; net leverage 2.7x.
Outlook and guidance
Fiscal 2026 adjusted EBITDA guidance narrowed to $400–$420 million; sales guidance $1,835–$1,905 million.
Double-digit-plus adjusted EPS growth targeted; ongoing free cash flow conversion expected at ~50% of adjusted EBITDA, with $100 million capex.
Calvert City and weather disruptions to impact Q2 by ~$11 million, with most recovery expected in Q3 and Q4.
Life Sciences and Personal Care expected to remain resilient; Specialty Additives and Intermediates to see gradual, regionally uneven recovery.
Prudent approach to inventory and production management, with focus on long-term value creation.
- TimeTickerHeadlineOpen
- KE
Medical sales surged 15% in Q2 2026 as guidance for sales and margins was raised. - GL
Earnings and sales grew across all segments, with higher 2026 guidance and ongoing share buybacks. - RSI
Record financial results, all motions passed, and LEAP project remains a strategic priority. - COST
January sales climbed 9.3% to $21.33B, with digital sales up 34.4%. - FR
FFO per share rose 11.7% in 2025, with robust rental growth and a higher dividend. - ALCO
Land sales and leasing drove improved profitability and strong liquidity as citrus operations ended. - PAHC
Net sales and profit surged on acquisition, with raised outlook and strong liquidity. - PTC
Q1'26 saw double-digit growth, margin gains, and major share repurchases, with a strong FY'26 outlook. - MKL
Operating income rose to $3.2B, with broad-based growth and improved insurance profitability. - UHAL
Q3 net loss of $37M on higher costs and depreciation, but self-storage revenue increased.
Next Ashland earnings date
Next Ashland earnings date
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
Frequently asked questions
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Explore our global coverage
)
)